Neurological Disease

  • Angels García-Cazorla
  • Nicole I. Wolf
  • Georg F. Hoffmann

Key Facts

  • The correct diagnosis of inherited metabolic diseases that affect the nervous system primarily is a major challenge because the same neurological symptoms and often even disease course may be caused by non-metabolic disorders.

  • Neurometabolic diseases often start with common and non-specific signs, such as isolated developmental delay/mental retardation, seizures, dystonia, or ataxia. They are especially to be suspected when the course of the disease is progressive or when additional neurological systems or other organs become involved. An important clue is the co-existence of different neurological features that cannot be explained by a “simple” neuroanatomic approach.

  • Acute or recurrent attacks of neurological manifestations such as coma, ataxia or abnormal behaviour are major presenting features especially in the late-onset inborn errors of metabolism (see also B2.7).

  • The initial diagnostic approach to these disorders is based on a few metabolic screening tests. It is important that the biologic fluids are collected at the time of the acute attack. And always consider treatable disorders first when choosing your plan of investigations.

  • Metabolic investigations are usually not indicated in children with moderate static developmental delay, isolated delay of speech development in early childhood, occasional seizures, e.g. during fever, or well-defined epileptic syndromes. Other genetic aetiologies outside the metabolic field have also been considered, especially as causes of mental retardation, ataxia, dystonia, and spastic paraplegia.


Inborn Error Mitochondrial Disorder Neuronal Ceroid Lipofuscinoses Glutaric Aciduria Type Biotinidase Deficiency 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Key References

  1. American Academy of Child and Adolescent Psychiatry Working Group on Quality Issues (1999) Practice parameters for the assessment and treatment of children, adolescents, and adults with mental retardation and comorbid mental disorders. J Am Acad Child Adolesc Psychiatry 38(12 Suppl):5S–31SCrossRefGoogle Scholar
  2. Assmann B, Surtees R, Hoffmann GF (2003) Approach to the diagnosis of neurotransmitter diseases exemplified by the differential diagnosis of childhood-onset dystonia. Ann Neurol 54(Suppl 6):S18–24PubMedCrossRefGoogle Scholar
  3. Barkovich AJ (2005) Magnetic resonance techniques in the assessment of myelin and myelination. J Inherit Metab Dis 28:311–343PubMedCrossRefGoogle Scholar
  4. Fernández-Álvarez E, Aicardi J (2001) Movement disorders in children. Mac Keith Press, LondonGoogle Scholar
  5. García-Cazorla A (2008) Neurometabolic diseases: guidance for neuropaediatricians. Rev Neurol 47(Suppl 1):S55–63PubMedGoogle Scholar
  6. Germain DP, Avan P, Chassaing A, Bonfils P (2002) Patients affected with Fabry disease have an increased incidence of progressive hearing loss and sudden deafness: an investigation of twenty-two hemizygous male patients. BMC Med Genet 11(3):10CrossRefGoogle Scholar
  7. Gordon N (2007) Sjögren-Larsson syndrome. Dev Med Child Neurol 49:152–154PubMedCrossRefGoogle Scholar
  8. Jinnah HA, Visser JE, Harris JC et al (2006) Lesch-Nyhan Disease International Study Group. Delineation of the motor disorder of Lesch-Nyhan disease. Brain 129:1201–1217PubMedCrossRefGoogle Scholar
  9. Kokotas H, Petersen MB, Willems PJ (2007) Mitochondrial deafness. Clin Genet 71:379–391PubMedCrossRefGoogle Scholar
  10. Lyon G, Fattal-Valevski A, Kolodny EH (2006) Leukodystrophies: clinical and genetic aspects. Top Magn Reson Imaging 17:219–242PubMedCrossRefGoogle Scholar
  11. Morgan NV, Westaway SK, Morton JEV et al (2006) PLA2G6, encoding a phospholipase A2, is mutated in neurodegenera-tive disorders with high brain iron. Nat Genet 38:752–754PubMedCrossRefGoogle Scholar
  12. Moser H (1997) Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy. Brain 120:1485–1508PubMedCrossRefGoogle Scholar
  13. Nance WE (2003) The genetics of deafness. Ment Retard Dev Disabil Res Rev 9:109–119PubMedCrossRefGoogle Scholar
  14. Parker CC, Evans OB (2003) Metabolic disorders causing childhood ataxia. Semin Pediatr Neurol 10:193–199PubMedCrossRefGoogle Scholar
  15. Poretti A, Wolf NI, Boltshauser E (2008) Differential diagnosis of cerebellar atrophy in childhood. Eur J Pediatr Neurol 123:155–167CrossRefGoogle Scholar
  16. Roach ES, Golomb MR, Adams R et al (2008) Management of stroke in infants and children. Stroke 39:1–48CrossRefGoogle Scholar
  17. Scaglia F, Lee B (2006) Clinical, biochemical, and molecular spectrum of hyperargininemia due to arginase I deficiency. Am J Med Genet C Semin Med Genet 142:113–120Google Scholar
  18. Schiffmann R, van der Knaap MS (2004) The latest on leu-kodystrophies. Curr Opin Neurol 17:187–192PubMedCrossRefGoogle Scholar
  19. Sedel F, Fontaine B, Saudubray JM (2007) Hereditary spastic paraparesis in adults associated with inborn errors of metabolism: a diagnostic approach. J Inherit Metab Dis 30:855–864PubMedCrossRefGoogle Scholar
  20. Shevell M, Ashwal S, Donley D et al (2003) Practice parameter: evaluation of the child with global developmental delay. Neurology 60:367–380PubMedCrossRefGoogle Scholar
  21. Surtees R, Wolf N (2007) Treatable neonatal epilepsy. Arch Dis Child 92:659–661PubMedCrossRefGoogle Scholar
  22. van der Knaap MS, Breiter SN, Naidu S et al (1999) Defining and categorizing leukoencephalopathies of unknown origin: MR imaging approach. Radiology 213:121–133PubMedGoogle Scholar
  23. Van Karnebeek CDM, Jansweijer MCE, Leenders AGE et al (2005) Diagnostic investigations in individuals with mental retardation. Eur J Hum Genet 13:6–25PubMedCrossRefGoogle Scholar
  24. Wolf NI, Bast T, Surtees R (2005) Epilepsy in inborn errors of metabolism. Epileptic Disord 7:67–81PubMedGoogle Scholar
  25. Zschocke J, Hoffmann GF (2004) Vademecum Metabolicum. Manual of metabolic paediatrics, 2nd edn. Schattauer, StuttgartGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2010

Authors and Affiliations

  • Angels García-Cazorla
    • 1
  • Nicole I. Wolf
    • 2
  • Georg F. Hoffmann
    • 3
  1. 1.Servicio de NeurologiaHospital Sant Joan de DeuBarcelonaSpain
  2. 2.Department of Child NeurologyVU Medisch CentrumAmsterdamThe Netherlands
  3. 3.University Children's HospitalRuprecht-Karls-UniversityHeidelbergGermany

Personalised recommendations